Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis: a double-blind cross-over comparison with indomethacin. 1976

B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae

In a double-blind cross-over trial, ketoprofen was found to be as effective as indomethacin in the treatment of rheumatoid arthritis. Side-effects, particularly headache and vertigo, were less common in patients receiving ketoprofen.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001577 Benzophenones Derivatives of benzophenone (with the structural formula phenyl-(C

Related Publications

B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
May 1979, Rheumatology and rehabilitation,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
January 1976, The Journal of international medical research,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
January 1976, Scandinavian journal of rheumatology. Supplement,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
February 1974, Rheumatology and rehabilitation,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
April 1975, European journal of clinical pharmacology,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
January 1976, Scandinavian journal of rheumatology. Supplement,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
January 1981, The British journal of clinical practice,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
January 1976, Scandinavian journal of rheumatology. Supplement,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
May 1973, Rheumatology and rehabilitation,
B Kirchheiner, and J Fossgreen, and E Tophoj, and E Zachariae
January 1982, Scandinavian journal of rheumatology,
Copied contents to your clipboard!